by synergycap1 | Jul 26, 2017 | Bad Credit Loans, Bank Lending, Business Loans, Capital, Non-Bank Loans, Working Capital
Free Webinar | August 16th Find out how to optimize your website to give your customers experiences that will have the biggest ROI for your business. Register Now » To all of the writers of articles out there labeling millennials as lazy, entitled navel-gazers,...
by synergycap1 | Jul 26, 2017 | Bad Credit Loans, Bank Lending, Business Loans, Capital, Non-Bank Loans, Working Capital
Free Webinar | August 16th Find out how to optimize your website to give your customers experiences that will have the biggest ROI for your business. Register Now » Look, it’s fairly easy to dismiss The Chairless Chair — a wearable exoskeleton...
by synergycap1 | Jul 26, 2017 | Bad Credit Loans, Bank Lending, Business Loans, Capital, Non-Bank Loans, Working Capital
My friend asked for advice on her pitch deck. She sent me two copies (always a worry). The first pitch deck looked pretty good because she’s clever. I wondered why the second deck. I opened the file and there were 30 slides, all filled with text!...
by synergycap1 | Jul 26, 2017 | Bad Credit Loans, Bank Lending, Business Loans, Finance, Working Capital
More jobs and cash have landed at Chicago Rockford International Airport, where cargo volume is up nearly 40% for the first six months of the year compared with the first half of 2016. The increase of 148.3 million pounds of landed cargo weight occurred after ABX Air...
by synergycap1 | Jul 26, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Working Capital
The strangely pleasant whiff of gas, the burble of the engine, the acrid stench of exhaust fumes. We all know that, sooner or later, these things will become little more than nostalgia as cars go all-electric. And in the U.K., at least, we now have a date...
by synergycap1 | Jul 26, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
By STEPHANIE CLIFFORD July 26, 2017 In February 2013, Martin Shkreli was contemplating a deal that involved acquiring shares of Retrophin, the pharmaceutical company he ran, at below the market price. His lawyer advised him to be careful, writing: “Not...
